Literature DB >> 4165068

Chronic lymphadenopathy simulating malignant lymphoma.

V C Canale, C H Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4165068     DOI： 10.1016/s0022-3476(67)80262-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  27 in total

1.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Authors:  Joao B Oliveira; Jack J Bleesing; Umberto Dianzani; Thomas A Fleisher; Elaine S Jaffe; Michael J Lenardo; Frederic Rieux-Laucat; Richard M Siegel; Helen C Su; David T Teachey; V Koneti Rao
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS).

Authors:  P D Arkwright; F Rieux-Laucat; F Le Deist; R F Stevens; B Angus; A J Cant
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  "When in doubt..."?

Authors: 
Journal:  Br Med J       Date:  1968-04-06

4.  Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

Authors:  Aude Magerus-Chatinet; Bénédicte Neven; Marie-Claude Stolzenberg; Cécile Daussy; Peter D Arkwright; Nina Lanzarotti; Catherine Schaffner; Sophie Cluet-Dennetiere; Filomeen Haerynck; Gérard Michel; Christine Bole-Feysot; Mohammed Zarhrate; Isabelle Radford-Weiss; Serge P Romana; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

Review 5.  Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunity.

Authors:  Sabine Adam-Klages; Dieter Adam; Ottmar Janssen; Dieter Kabelitz
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  [Chronic pseudomalignant immuneproliferation (Canale-Smith syndrome) (author's transl)].

Authors:  K Kellerer; I Mutz
Journal:  Eur J Pediatr       Date:  1976-02-04       Impact factor: 3.183

Review 7.  Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors:  Pu Li; Ping Huang; Ye Yang; Mu Hao; Hongwei Peng; Fei Li
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 8.  Rare phenotypes in the understanding of autoimmunity.

Authors:  Yvonne Zeissig; Britt-Sabina Petersen; Andre Franke; Richard S Blumberg; Sebastian Zeissig
Journal:  Immunol Cell Biol       Date:  2016-10-11       Impact factor: 5.126

9.  Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).

Authors:  V Koneti Rao; Susan Price; Katie Perkins; Patricia Aldridge; Jean Tretler; Joie Davis; Janet K Dale; Fred Gill; Kip R Hartman; Linda C Stork; David J Gnarra; Lakshmanan Krishnamurti; Peter E Newburger; Jennifer Puck; Thomas Fleisher
Journal:  Pediatr Blood Cancer       Date:  2009-07       Impact factor: 3.167

10.  A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1.

Authors:  S H Pearce; T Cheetham; H Imrie; B Vaidya; N D Barnes; R W Bilous; D Carr; K Meeran; N J Shaw; C S Smith; A D Toft; G Williams; P Kendall-Taylor
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.